Jiangsu Hengrui Medicine
600276.SS
#508
Rank
NZ$65.46 B
Marketcap
$10.26
Share price
-0.27%
Change (1 day)
-0.28%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$21.13 M

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total debt is NZ$21.13 M. A companyโ€™s total debt is the sum of all current and non-current debts.

Jiangsu Hengrui Medicine - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2022-12-31NZ$0.31 B793.97%
2021-12-31NZ$34.73 M
2015-12-31NZ$2.26 M9.96%
2014-12-31NZ$2.05 M-48.84%
2013-12-31NZ$4.02 M105.68%
2012-12-31NZ$1.95 M-52.02%
2011-12-31NZ$4.07 M3.58%
2010-12-31NZ$3.93 M93.85%
2009-12-31NZ$2.03 M
2007-12-31NZ$10.64 M21.97%
2006-12-31NZ$8.72 M0.28%
2005-12-31NZ$8.7 M-48.14%
2004-12-31NZ$16.78 M-76.27%
2003-12-31NZ$70.72 M19.44%
2002-12-31NZ$59.21 M-19.21%
2001-12-31NZ$73.29 M47.16%
2000-12-31NZ$49.8 M3.59%
1999-12-31NZ$48.07 M45.42%
1998-12-31NZ$33.06 M21.38%
1997-12-31NZ$27.23 M